About Electrophysiology Therapeutic Devices
The EP therapeutic devices constitute nearly half of the global EP devices market. These devices are used for corrective procedures for the abnormal functioning of the heart. EP therapeutic devices such as pacemakers and ablation catheters are used in most diagnosis cases for cardiovascular diseases (CVDs). The ablation catheter is one of the most common EP devices used for cardiac arrhythmia. Based on the product, the market is segmented into ICDs, cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and ablation catheters.
Technavio’s analysts forecast the global electrophysiology therapeutic devices market to grow at a CAGR of 9.38% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global electrophysiology therapeutic devices market for 2017-2021. To calculate the market size, the report considers volume and value of the global EP therapeutic devices market.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Electrophysiology Therapeutic Devices Market 2017-2021
Technavio recognizes the following companies as the key players in the global electrophysiology therapeutic devices market: Boston Scientific, Medtronic, and St. Jude Medical.
Other Prominent Vendors in the market are: AngioDynamics, Biosense Webster, BIOTRONIK, Cardiac Science, Cook Medical, GE Healthcare, Imricor, LivaNova, Maquet Getinge Group (Atrium Medical), MicroPortScientific, and Vimecon.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is development of leadless pacemaker. Technological advancements have driven the development of leadless pacemakers. For instance, Nanostim leadless pacemaker developed by St. Jude Medical received the CE mark for the commercial launch in the European market. Leadless pacemakers are developed to reduce the risk of pocket infections, lead dislodgement, fracture or perforation, and extrusion of the pacemaker through the skin.”
According to the report, one driver in the market is increasing incidence of cardiac arrhythmia cases. Cardiac arrhythmia is the abnormal rhythm of the heart or irregular heartbeat resulting due to tachycardia (faster heart beat), bradycardia (slower heartbeat), stroke, or cardiac arrest. Cardiac ablation is used as a corrective measure for treating cardiac arrhythmia. EP therapeutic devices are used to monitor the heart beat and facilitate the treatment of the abnormal heart function. The growing incidence of cardiac arrhythmia and CVD cases is driving the growth of many market segments in the EP devices market such as ECG devices, pacemakers, CRT devices, and ablation catheters.
Further, the report states that one challenge in the market is high cost of ablation procedures. Due to technological advances, new tools and techniques are being used for performing ablation procedures in cardiac patients. 3D electro-anatomical mapping and remote catheter monitoring are commonly used during the cardiac ablation procedure. electrophysiologists use robotic technology during the interventional procedures. The magnetic remote monitoring systems are being used in few developed countries with well-equipped healthcare facilities. This system uses magnetic field for assisting navigation of catheters.
Boston Scientific, Medtronic, St. Jude Medical, AngioDynamics, Biosense Webster, BIOTRONIK, Cardiac Science, Cook Medical, GE Healthcare, Imricor, LivaNova, Maquet Getinge Group (Atrium Medical), MicroPortScientific, and Vimecon.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook